BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
David Crottès, Lily Yeh Jan. The multifaceted role of TMEM16A in cancerCell Calcium 2019; 82: 102050 doi: 10.1016/j.ceca.2019.06.004
2
Soz Abdulrahman Ahmad-Nielsen, Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinomaPathology - Research and Practice 2020; 216(6): 152985 doi: 10.1016/j.prp.2020.152985
3
Veethika Pandey, Peter Storz. Targeting the tumor microenvironment in pancreatic ductal adenocarcinomaExpert Review of Anticancer Therapy 2019; 19(6): 473 doi: 10.1080/14737140.2019.1622417
4
Cédric Zeltz, Irina Primac, Pugazendhi Erusappan, Jahedul Alam, Agnes Noel, Donald Gullberg. Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrinsSeminars in Cancer Biology 2020; 62: 166 doi: 10.1016/j.semcancer.2019.08.004
5
Jeffrey Norton, Deshka Foster, Malini Chinta, Ashley Titan, Michael Longaker. Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer TreatmentCancers 2020; 12(5): 1347 doi: 10.3390/cancers12051347
6
Sonia Zaghdoudi, Emilie Decaup, Ismahane Belhabib, Rémi Samain, Stéphanie Cassant‐Sourdy, Julia Rochotte, Alexia Brunel, David Schlaepfer, Jérome Cros, Cindy Neuzillet, Manon Strehaiano, Amandine Alard, Richard Tomasini, Vinothini Rajeeve, Aurélie Perraud, Muriel Mathonnet, Oliver MT Pearce, Yvan Martineau, Stéphane Pyronnet, Corinne Bousquet, Christine Jean. FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer EMBO Molecular Medicine 2020;  doi: 10.15252/emmm.202012010